Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Oral ondansetron cost saving in paediatric cancer patients

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Oral ondansetron cost saving in paediatric cancer patients. Pharmacoecon. Outcomes News 315, 8 (2001). https://doi.org/10.1007/BF03280379

    Download citation

    Keywords

    • Success Rate
    • Paediatric Patient
    • Health Economic
    • Outcome News
    • Chemotherapy Regimen